Good Relations Pharma team, De Facto, wins international communications brief from ClinTec International.

Good Relations’ pharma division, De Facto has been appointed by ClinTec International, the rapidly expanding Contract Research Organisation (CRO), to undertake a comprehensive trade media communications campaign.

The De Facto team which specialise in life science and biotech PR, will raise ClinTec’s profile internationally amongst key target audiences in the pharmaceutical and biopharmaceutical sectors and position the company as a leading, international provider of quality clinical research services. De Facto’s specific remit focuses primarily in generating news coverage in key print and online life science publications that are read by relevant procurement decision-makers and opinion formers in the life science industry.

Good Relations is part of the Bell Pottinger Group. The agency has already, in its first month, worked with ClinTec’s in-house team to develop an extensive media outreach programme, delivering significant coverage in leading UK, pan European, US and Middle East based life science focused publications.

De Facto account director, Tristan Jervis, who will lead the account, commented: “This is a very exciting win for our agency. Indeed, ClinTec has grown very rapidly in recent years and deserves full recognition as a solid player in the international clinical research field with a truly international offering. We look forward to making our contribution towards building ClinTec’s reputation as a leading international CRO, with an innovative and effective business model, a real international presence, possessing specialist expertise in addressing the world’s most critical therapeutic areas where unmet needs exist".

Dr Rabinder Buttar, CEO of the ClinTec International, added: “We are delighted to have engaged De Facto to build our international profile, and drive forward and enhance industry awareness of our contract research capabilities. We have grown our offering considerably in recent years covering all primary and emerging markets for clinical research, and we now look forward to utilising the agency to reinforce and foster ClinTec’s growing reputation".

For further information please call Malcolm Munro, Good Relations on 07795 013006

Visit the De Facto Communications site at www.defacto.com

« Back